Local recurrence of hepatocellular carcinoma after radiofrequency ablation

被引:3
作者
Liao, Wang-Jun [1 ]
Shi, Min [1 ]
Chen, Jin-Zhang [1 ]
Li, Ai-Min [1 ]
机构
[1] So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou 510515, Guangdong, Peoples R China
关键词
Hepatocellular carcinoma; Radiofrequency ablation; Recurrence; CHRONIC HEPATITIS-B; RISK-FACTORS; WESTERN CENTER; THERAPY; LAMIVUDINE; COMPLICATIONS; MANAGEMENT; EFFICACY; DISEASE; JAPAN;
D O I
10.3748/wjg.v16.i40.5135
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A 51-year-old Chinese male with a 20-year history of hepatitis B was diagnosed with hepatocellular carcinoma in the right anterior portion of the liver; sized 3.5 cm x 3.2 cm, and was treated with radiofrequency ablation (RFA) on December 18, 2001. The patient did not receive antiviral therapy for hepatitis B virus after RFA. The treated lesion reduced gradually and reached its minimum size of 1.7 cm x 1.5 cm seven years later on November 18, 2008. However computed tomography findings revealed that a recurrence lesion of 6.0 cm x 4.8 cm which was histologically confirmed overlapped the previous treated lesion at the 8th year on December 3, 2009. Although recurrence at 8 years after curative RFA is a rare event, such a possibility must be kept in mind. To find and treat the recurrence lesion promptly, long-term and close monitoring is warranted after RFA. Meanwhile, the recurrence-prevention therapy is as important as close monitoring for those patients with a history of hepatitis B. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:5135 / 5138
页数:4
相关论文
共 22 条
[1]  
Bolton JS, 1999, ANN SURG, V229, P799
[2]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[3]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[4]   An analysis of 412 cases of hepatocellular carcinoma at a western center [J].
Fong, YM ;
Sun, RL ;
Jarnagin, W ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 229 (06) :790-799
[5]  
Hiraoka A, 2008, HEPATO-GASTROENTEROL, V55, P2171
[6]   Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function [J].
Hong, SN ;
Lee, SY ;
Choi, MS ;
Lee, JH ;
Koh, KC ;
Paik, SW ;
Yoo, BC ;
Rhee, JC ;
Choi, D ;
Lim, HK ;
Lee, KW ;
Joh, JW .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (03) :247-252
[7]  
Ikeda K, 2007, INT J ONCOL, V31, P485
[8]   Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients [J].
Ishikawa, Toru .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (40) :6140-6144
[9]   Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors [J].
Kim, Young-sun ;
Rhim, Hyunchul ;
Cho, On Koo ;
Koh, Byung Hee ;
Kim, Yongsoo .
EUROPEAN JOURNAL OF RADIOLOGY, 2006, 59 (03) :432-441
[10]   Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma [J].
Lam, Vincent Wai-To ;
Ng, Kelvin Kwok-Chai ;
Chok, Kenneth Siu-Ho ;
Cheung, Tan-To ;
Yuen, Jimmy ;
Tung, Helen ;
Tso, Wai-Kuen ;
Fan, Sheung-Tat ;
Poon, Ronnie T. P. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (01) :20-29